I found it interesting that Phil referenced a partner in the video. Dr T had altered the language to 'liquidity event' post 5 path. Partnership off the back of the COH study is the most likely scenario.
Not that this is of concern. I've got a nice round number and never felt so nonchalant about a holding before. Bisantrene works, it looks like the COH study will open a whole new realm of treatment opportunities. Race will get gobbled up - the unknowns are who, when and how much.
All IMO.
Medical / Clinical Discussions, page-200
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |